University of Pittsburgh Seal Link to Homepage
Archive Service Center Link University Library System Link

Notice: Undefined variable: mapList in D:\Sites\starzl\appendix\scripts\timesCited.php on line 40

Cancer Immunology Appendix

Article Information # of Cites
Starzl TE, Nalesnik MA, Porter KA, Ho M, Iwatsuki S, Griffith BP, Rosenthal JT, Hakala TR, Shaw BW Jr, Hardesty RL, Atchison RW, Jaffe R, Bahnson HT: Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1:583-587, 1984.
Nalesnik MA, Jaffe R, Starzl TE, Demetris AJ, Porter K, Burnhan JA, Makowka L, Ho M, Locker J: The pathology of post transplant lymphoproliferative disorders occurring in the setting of cyclosporin A-prednisone immunosuppression. Am J Pathol 133:173-192, 1988.
Penn I, Hammond W, Brettschneider L, Starzl TE: Malignant lymphomas in transplantation patients. Transplant Proc 1:106-112, 1969.
Ho M, Miller G, Atchison RW, Breinig MK, Dummer JS, Andiman W, Starzl TE, Eastman R, Griffith BP, Hardesty RL, Bahnson HT, Hakala TR, Rosenthal JT: Epstein-Barr virus infections and DNA hybridization studies in post-transplantation lymphoma and lymphoproliferative lesions: Role of primary infection. J Infect Dis 152:876-886, 1985.
Ho M, Jaffe R, Miller G, Breining MK, Dummer JS, Makowka L, Atchison RW, Karrer F, Nalesnik MA, Starzl TE: The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 45:719-727, 1988.
Penn I, Starzl TE: Malignant tumors arising de novo in immunosuppressed organ transplant recipients. Transplantation 14:407-417, 1972.
Starzl TE, Porter KA, Andres G, Halgrimson CG, Hurwitz R, Giles G, Terasaki PI, Penn I, Schroter GT, Lilly J, Starkie SJ, Putnam CW: Long-term survival after renal transplantation in humans: With special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG, and recipient malignancy. Ann Surg 172:437-472, 1970.
Penn I, Halgrimson CG, Starzl TE: De novo malignant tumors in organ transplant recipients. Transplant Proc 3:773-778, 1971.
Yokoyama I, Carr B, Saitsu H, Iwatsuki S, Starzl TE: Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer 68:2095-2100, 1991.
Randhawa PS, Jaffe R, Demetris AJ, Nalesnik M, Starzl TE, Chen YY, Weiss LM: Expression of Epstein-Barr virus-encoded small RNA by the gene in liver specimens from liver transplant recipients with post-transplant lymphoproliferative disease. N Eng J Med 327:1710-1714, 1992.
Yokoyama I, Todo S, Iwatsuki S, Starzl TE: Liver transplantation in the treatment of primary liver cancer. Hepatogastroenterology 37:188-193, 1990.
Nalesnik MA, Makowka L, Starzl TE: The diagnosis and treatment of post transplant lymphoproliferative disorders. In: Current Problems In Surgery (M Ravitch, ed) Year Book Medical Publishers, Inc, Chicago, IL, 1988, 25:367-472.
Starzl, TE and Penn, I and Putnam, CW and Groth, CG and Halgrimson, CG (1971) Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy. Transplantation Reviews, 7. pp. 112-145. 1971
Penn I, Starzl TE: Immunosuppression and cancer. Transplant Proc 5:943-947, 1973.
Penn I, Starzl TE: A summary of the status of de novo cancer in transplant recipients. Transplant Proc 4:719-732, 1972.
Breinig MK, Zitelli B, Starzl TE, Ho M: Epstein-Barr virus, cytomegalovirus and other virus infections in children after liver transplantation. J Infect Dis 156:273-279, 1987.
Shapiro R, Nalesnik M, McCauley J, Fedorek S, Jordan ML, Scantlebury VP, Jain A, Vivas C, Ellis D, Lombardozzi-Lane S, Randhawa P, Johnston J, Hakala TR, Simmons RL, Fung JJ, Starzl TE: Post-transplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation 68:1851-1854, 1999.
Nalesnik MA, Rao AS, Furukawa H, Pham S, Zeevi A, Fung JJ, Klein G, Gritsch A, Elder E, Whiteside TL, Starzl TE: Autologous lymphokine-activated killer (LAK) cell therapy of EBV+ and EBV- lymphoproliferative disorders arising in organ transplant recipients. Transplantation 63:1200-1205, 1997.
Randhawa PS, Markin RS, Starzl TE, Demetris AJ: Epstein-Barr virus-associated syndromes in immunosuppressed liver transplant recipients. Am J Surg Pathol 14:538-547, 1990.
Reyes J, Tzakis A, Green M, Nour B, Nalesnik M, Van Thiel D, Martin M, Breinig MK, Fung JJ, Cooper M, Starzl TE: Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression. Transplant Proc 23:3044-3046, 1991.
Iwatsuki S, Klintmalm GBG, Starzl TE: Total hepatectomy and liver replacement (orthotopic liver transplantation) for primary hepatic malignancy. World J Surg 6:81-85, 1982.
Starzl TE, Penn I, Halgrimson CT: Immunosuppression and malignant neoplasms. N Engl J Med 283:934-935, 1970.
Alpert E, Starzl TE, Schur PH, Isselbacher KJ: Serum alphafetoprotein in hepatoma patients after liver transplantation. Gastroenterology 61:144-148, 1971.
Randhawa PS, Jaffe R, Demetris AJ, Nalesnik M, Starzl TE, Chen Y-Y, Weiss LM: The systemic distribution of Epstein-Barr virus genomes in fatal post-transplantation lymphoproliferative disorders. An in situ hybridization study. Am J Pathol 138:1027-1033, 1991.
Starzl TE: History of Clinical Transplantation. World J Surg 24:759-782, 2000. (Also published verbatim in: Starzl TE: A History of Clinical Transplantation. In: Surgery: Basic Science and Clinical Evidence. (eds. JA Norton, R Bollinger, AE Chang, SJ Mulvihill, S Lowry, H Pass, R Thompson). Springer Verlag, New York, NY. 2001 and 2008, 1st and 2nd editions).
Iwatsuki S, Starzl TE: The role of liver transplantation in the treatment of hepatocellular carcinoma. Semin Surg Oncol 9:337-340, 1993.
Nalesnick MA, Locker J, Jaffe R, Reyes J, Cooper M, Fung J, Starzl TE: Experience with posttransplant lymphoproliferative disorders in solid organ transplant recipients. Clin Transplant 6:249-252, 1992.
Reyes J, Tzakis AG, Bonet H, Green M, Yunis E, Nalesnik M, Nour B, Kocoshis S, Abu-Elmagd K, Todo S, Starzl TE: Lymphoproliferative disease after intestinal transplantation under primary FK506 immunosuppression. Transplant Proc 26:1426-1427, 1994.
Nalesnik MA, Locker J, Jaffe R, Demetris AJ, Hartle K, Burnham JA, Makowka L, Starzl TE: Clonal characteristics of posttransplant lymphoproliferative disorders. Transplant Proc 20:280-283, 1988.
Yokoyama I, Sheahan DG, Carr B, Kakizoe S, Selby R, Tzakis AG, Todo S, Iwatsuki S, Starzl TE: Clinicopathologic factors affecting patient survival and tumor recurrence after orthotopic liver transplantation for hepatocellular carcinoma. Transplant Proc 23:2194-2196, 1991.
Marsh JW Jr, Esquivel CO, Makowka L, Todo S, Gordon RD, Tzakis A, Miller C, Morris M, Staschak S, Iwatsuki S, Mazariegos J, Kapadia S, Starzl TE: Accidental transplantation of malignant tumor from a donor to multiple recipients. Transplantation 44:449 450, 1987.
Rosenthal JT, Iwatsuki S, Starzl TE, Taylor RJ, Hakala TR: Histiocytic lymphoma in renal transplant patients receiving cyclosporine. Transplant Proc 15:2805-2807, 1983.
Groth CG, Brent LB, Calne RY, Dausset JB, Good RA, Murray JE, Shumway NE, Schwartz RS, Starzl TE, Terasaki PI, Thomas ED, van Rood JJ: Historical landmarks in clinical transplantation: conclusions from the concensus conference at the University of California, Los Angeles (UCLA). World J Surg 24:834-843, 2000.
Ove P, Coetzee ML, Scalamogna P, Francavilla A, Starzl TE: Isolation of an autocrine growth factor from hepatoma HTC-SR cells. J Cell Physiol 131:165-174, 1987.
Nalesnik M, Jaffe R, Reyes J, Mazariegos G, Fung JJ, Starzl TE, Abu-Elmagd K: Posttransplantation lymphoproliferative disorders in small bowel allograft recipients. Transplant Proc 32:1213, 2000.
Kadry Z, Bronsther O, Van Thiel DH, Fung JJ, Starzl TE: Kaposis sarcoma in two primary liver allograft recipients occurring under FK506 immunosuppression. Clin Transplant 7:188-194, 1993.
Nakazato P, Esquivel CO Urbach AH, Makowka L, Scantlebury V, Jaffe R, Starzl TE: Lymphoma and hypercalcemia in a pediatric orthotopic liver transplant patient. Transplantation 48:1003-1006, 1989.
Wu TT, Swerdlow S, Locker J, Randhawa PS, Yunis E, Reyes J, Fung JJ, Starzl TE, Nalesnik MA: Pathologic analysis of recurrent posttransplant lymphoproliferative disorders. Transplant Proc 27:1193-1194, 1995.
23-09-2017 11:41:11